Medtronic reported today that its Infuse Bone Graft product, a key part of its spinal business, remains a drag on its earnings, with sales of the device declining worse than expected. To offset some of its losses, Medtronic has laid off employees in its spine division, Parker Waichman LLP reports....
More...
